Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis.

ABSTRACT:

SUBMITTER: Fletcher MC 

PROVIDER: S-EPMC8850518 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature